The estimated Net Worth of David Alan Urbanek is at least $2.84 Millón dollars as of 18 November 2019. Mr. Urbanek owns over 228 units of Elanco Animal Health Inc stock worth over $1,100 and over the last 6 years he sold ELAN stock worth over $0. In addition, he makes $2,839,990 as Executive Vice President - Manufacturing y Quality at Elanco Animal Health Inc.
Sign up
Mr. Urbanek ELAN stock SEC Form 4 insiders trading
David has made over 2 trades of the Elanco Animal Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 228 units of ELAN stock worth $5,987 on 18 November 2019.
The largest trade he's ever made was buying 500 units of Elanco Animal Health Inc stock on 24 September 2018 worth over $12,000. On average, David trades about 40 units every 23 days since 2018. As of 18 November 2019 he still owns at least 76 units of Elanco Animal Health Inc stock.
You can see the complete history of Mr. Urbanek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Urbanek biography
David A. Urbanek serves as Executive Vice President - Manufacturing, Quality of the Company. Mr. Urbanek served as Vice President of Manufacturing at the Elanco Animal Health division of Lilly from November 2017 to September 2018. Prior to that, Mr. Urbanek served in various leadership roles for Lilly’s Manufacturing division, including Senior Director of Emerging Markets Manufacturing from 2013 to 2017, Senior Director of Global Diabetes Manufacturing from 2011 to 2013, and Senior Director of External Drug Products Operations from 2009 to 2011.
What is the salary of David Urbanek?
As the Executive Vice President - Manufacturing y Quality of Elanco Animal Health Inc, the total compensation of David Urbanek at Elanco Animal Health Inc is $2,839,990. There are 3 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of $15,801,800.
How old is David Urbanek?
David Urbanek is 53, he's been the Executive Vice President - Manufacturing y Quality of Elanco Animal Health Inc since 2018. There are 13 older and 14 younger executives at Elanco Animal Health Inc. The oldest executive at Elanco Animal Health Inc is R. David Hoover, 74, who is the Independent Chairman of the Board.
What's David Urbanek's mailing address?
David's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Insiders trading at Elanco Animal Health Inc
Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital... y R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.
What does Elanco Animal Health Inc do?
elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
What does Elanco Animal Health Inc's logo look like?
Complete history of Mr. Urbanek stock trades at Elanco Animal Health Inc
Elanco Animal Health Inc executives and stock owners
Elanco Animal Health Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Simmons,
President, Chief Executive Officer, Director -
Sarena Lin,
Executive Vice President, Global Marketing, Corporate Strategy and Transformation -
David Kinard,
Executive Vice President of Human Resources -
David Urbanek,
Executive Vice President - Manufacturing, Quality -
Aaron Schacht,
Executive Vice President - Innovation, Regulatory, Business Development -
Todd Young,
Chief Financial Officer, Executive Vice President -
Jeffrey N. Simmons,
Pres, CEO & Director -
Todd S. Young,
Exec. VP of Corp. Governance and Strategy & CFO -
R. David Hoover,
Independent Chairman of the Board -
Kapila Anand,
Independent Director -
Lawrence Kurzius,
Independent Director -
Michael Harrington,
Independent Director -
John Bilbrey,
Independent Director -
Denise Scots-Knight,
Independent Director -
Kirk McDonald,
Independent Director -
Deborah Kochevar,
Independent Director -
Art Garcia,
Independent Director -
Joshua Smiley,
Independent Director -
Aarti Shah,
Independent Director -
David Ricks,
Independent Director -
Carl McMillian,
Independent Director -
James Meer,
Chief Accounting Officer, Vice President -
Ramiro Cabral,
Executive Vice President - Elanco International -
Michael-Bryant Hicks,
Executive Vice President, General Counsel, Corporate Secretary -
Larbi Van Lier,
Sr. VP of Asia -
Shawn McKee,
Sr. VP of U.S. Companion Animal -
David Alan Urbanek,
Exec. VP of Manufacturing & Quality -
Ramiro Martin Cabral,
Exec. VP of Elanco International -
Racquel Harris Mason,
Exec. VP & Chief Marketing Officer -
Marcela A. Kirberger,
Exec. VP, Gen. Counsel & Corp. Sec. -
Tiffany Ann Kanaga,
Head of Investor Relations -
David S. Kinard,
Exec. VP of HR Corp. Affairs & Admin. -
Chris Keeley,
Sr. VP & Chief Information Officer -
James M. Meer,
VP & Chief Accounting Officer -
De Simas Jose Manuel Correia,
SEE REMARKS -
Lilly & Co Eli,
10% owner -
Timothy J Bettington,
SEE REMARKS -
Aktiengesellschaft Bayer Wo...,
-
Racquel Harris Mason,
See Remarks -
Dirk Ehle,
Ex VP & Pres Elanco Europe -
Joyce J. Lee,
Ex VP Prs US Pet Hlth Com Op -
Rajeev A. Modi,
SEE REMARKS -
Paul Herendeen,
-
Marcela A. Kirberger,
SEE REMARKS -
William F Doyle,
-
Scott D.Sachem Head Capital...,
-
Brabander Ellen De,
SEE REMARKS -
Shiv O'neill,
GC AND CORP SEC -
Grace Mc Ardle,
EVP, MANUFACTURING AND QUALITY